Fund profile
Tickers
IBB
Fund manager
Total assets
$8.24 bn
Liabilities
$787.66 mm
Net assets
$7.46 bn
Number of holdings
231.00
IBB stock data
Top 200 of 231 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 782.69 mm | 782.15 mm shares | 10.50 | Short-term investment vehicle | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 633.93 mm | 1.56 mm shares | 8.50 | Common equity | Long | USA |
AMGN AMGEN Inc. | 590.47 mm | 2.05 mm shares | 7.92 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 589.35 mm | 671.02 k shares | 7.90 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 584.62 mm | 7.22 mm shares | 7.84 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 298.70 mm | 1.29 mm shares | 4.01 | Common equity | Long | USA |
BIIB Biogen Inc | 278.14 mm | 1.07 mm shares | 3.73 | Common equity | Long | USA |
MRNA Moderna Inc | 245.91 mm | 2.47 mm shares | 3.30 | Common equity | Long | USA |
MTD Mettler-Toledo International, Inc. | 193.27 mm | 159.34 k shares | 2.59 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 178.52 mm | 932.64 k shares | 2.39 | Common equity | Long | USA |
ILMN Illumina Inc | 164.32 mm | 1.18 mm shares | 2.20 | Common equity | Long | USA |
WAT Waters Corp. | 144.87 mm | 440.01 k shares | 1.94 | Common equity | Long | USA |
BNTX BioNTech SE | 139.17 mm | 1.32 mm shares | 1.87 | Common equity | Long | Germany |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 133.01 mm | 1.38 mm shares | 1.78 | Common equity | Long | USA |
ARGX Argen X SE | 121.46 mm | 319.26 k shares | 1.63 | Common equity | Long | Netherlands |
Genmab A/S
|
114.14 mm | 3.58 mm shares | 1.53 | Common equity | Long | Denmark |
INCY Incyte Corp. | 103.90 mm | 1.65 mm shares | 1.39 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 93.90 mm | 712.67 k shares | 1.26 | Common equity | Long | USA |
BeiGene Ltd.
|
92.39 mm | 512.23 k shares | 1.24 | Common equity | Long | Cayman Islands |
TECH Bio-Techne Corp | 90.14 mm | 1.17 mm shares | 1.21 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 88.71 mm | 375.25 k shares | 1.19 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 75.98 mm | 240.06 k shares | 1.02 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 75.16 mm | 341.79 k shares | 1.01 | Common equity | Long | USA |
RGEN Repligen Corp. | 69.65 mm | 387.39 k shares | 0.93 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 63.47 mm | 658.24 k shares | 0.85 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 58.84 mm | 977.82 k shares | 0.79 | Common equity | Long | Cayman Islands |
CYTK Cytokinetics Inc | 58.34 mm | 698.78 k shares | 0.78 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 57.39 mm | 1.94 mm shares | 0.77 | Common equity | Long | USA |
MEDP Medpace Holdings Inc | 55.19 mm | 180.04 k shares | 0.74 | Common equity | Long | USA |
EXEL Exelixis Inc | 54.01 mm | 2.25 mm shares | 0.72 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 52.93 mm | 1.05 mm shares | 0.71 | Common equity | Long | USA |
NTRA Natera Inc | 51.44 mm | 821.15 k shares | 0.69 | Common equity | Long | USA |
BRKR Bruker Corp | 50.91 mm | 692.81 k shares | 0.68 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 50.11 mm | 699.62 k shares | 0.67 | Common equity | Long | USA |
Roivant Sciences Ltd.
|
44.74 mm | 3.98 mm shares | 0.60 | Common equity | Long | Bermuda |
APLS Apellis Pharmaceuticals Inc | 43.28 mm | 722.95 k shares | 0.58 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 41.66 mm | 663.42 k shares | 0.56 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 41.02 mm | 444.66 k shares | 0.55 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 39.44 mm | 704.71 k shares | 0.53 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 38.43 mm | 305.14 k shares | 0.52 | Common equity | Long | Denmark |
ACAD Acadia Pharmaceuticals Inc | 38.14 mm | 1.22 mm shares | 0.51 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 37.68 mm | 933.46 k shares | 0.51 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 36.08 mm | 976.13 k shares | 0.48 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
35.67 mm | 569.79 k shares | 0.48 | Common equity | Long | Switzerland |
Alkermes plc
|
34.01 mm | 1.23 mm shares | 0.46 | Common equity | Long | Ireland |
INSM Insmed Inc | 32.28 mm | 1.04 mm shares | 0.43 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 30.12 mm | 2.12 mm shares | 0.40 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 30.07 mm | 1.05 mm shares | 0.40 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 28.08 mm | 477.91 k shares | 0.38 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 26.54 mm | 555.10 k shares | 0.36 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 24.61 mm | 106.36 k shares | 0.33 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 23.12 mm | 755.47 k shares | 0.31 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 22.96 mm | 288.44 k shares | 0.31 | Common equity | Long | USA |
Biohaven Ltd.
|
22.08 mm | 515.81 k shares | 0.30 | Common equity | Long | Virgin Islands (British) |
KRYS Krystal Biotech Inc | 21.81 mm | 175.80 k shares | 0.29 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 21.76 mm | 472.33 k shares | 0.29 | Common equity | Long | Canada |
NTLA Intellia Therapeutics Inc | 19.99 mm | 655.60 k shares | 0.27 | Common equity | Long | USA |
IMVT Immunovant Inc | 19.06 mm | 452.53 k shares | 0.26 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 19.06 mm | 807.10 k shares | 0.26 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 18.72 mm | 1.91 mm shares | 0.25 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 18.30 mm | 610.58 k shares | 0.25 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 18.23 mm | 849.63 k shares | 0.24 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 17.59 mm | 382.57 k shares | 0.24 | Common equity | Long | USA |
Immunocore Holdings plc
|
17.41 mm | 254.88 k shares | 0.23 | Common equity | Long | UK |
FTRE Fortrea Holdings Inc | 17.13 mm | 490.84 k shares | 0.23 | Common equity | Long | USA |
OLK Olink Holding AB (publ) | 16.86 mm | 670.53 k shares | 0.23 | Common equity | Long | Sweden |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 16.67 mm | 9.86 mm shares | 0.22 | Common equity | Long | USA |
Grifols SA
|
16.44 mm | 1.42 mm shares | 0.22 | Common equity | Long | Spain |
NUVL Nuvalent Inc - Ordinary Shares | 15.58 mm | 211.76 k shares | 0.21 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 15.20 mm | 412.31 k shares | 0.20 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 15.18 mm | 426.64 k shares | 0.20 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 15.01 mm | 544.71 k shares | 0.20 | Common equity | Long | USA |
VCYT Veracyte Inc | 14.81 mm | 538.50 k shares | 0.20 | Common equity | Long | USA |
Zai Lab Ltd.
|
14.63 mm | 535.29 k shares | 0.20 | Common equity | Long | Cayman Islands |
ACLX Arcellx Inc | 14.57 mm | 262.61 k shares | 0.20 | Common equity | Long | USA |
GLPG Galapagos NV | 14.57 mm | 358.53 k shares | 0.20 | Common equity | Long | Belgium |
ARVN Arvinas Inc | 14.55 mm | 353.42 k shares | 0.20 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 14.35 mm | 403.39 k shares | 0.19 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 13.97 mm | 513.40 k shares | 0.19 | Common equity | Long | USA |
Prothena Corp. plc
|
13.75 mm | 378.27 k shares | 0.18 | Common equity | Long | Ireland |
DVAX Dynavax Technologies Corp. | 13.42 mm | 959.61 k shares | 0.18 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 13.19 mm | 361.46 k shares | 0.18 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 13.08 mm | 1.14 mm shares | 0.18 | Common equity | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 12.80 mm | 12.80 mm shares | 0.17 | Short-term investment vehicle | Long | USA |
VCEL Vericel Corp | 12.59 mm | 353.64 k shares | 0.17 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 12.02 mm | 1.48 mm shares | 0.16 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 11.34 mm | 592.29 k shares | 0.15 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 11.13 mm | 1.13 mm shares | 0.15 | Common equity | Long | USA |
Novocure Ltd.
|
10.77 mm | 721.37 k shares | 0.14 | Common equity | Long | Jersey |
SNDX Syndax Pharmaceuticals Inc | 10.74 mm | 497.22 k shares | 0.14 | Common equity | Long | USA |
INBX Inhibrx Inc | 9.79 mm | 257.73 k shares | 0.13 | Common equity | Long | USA |
XNCR Xencor Inc | 9.45 mm | 445.33 k shares | 0.13 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 9.38 mm | 230.08 k shares | 0.13 | Common equity | Long | Cayman Islands |
PTGX Protagonist Therapeutics Inc | 9.27 mm | 404.42 k shares | 0.12 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 9.20 mm | 361.28 k shares | 0.12 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 9.11 mm | 408.96 k shares | 0.12 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 8.93 mm | 1.49 mm shares | 0.12 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 8.81 mm | 979.62 k shares | 0.12 | Common equity | Long | Canada |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 8.79 mm | 123.07 k shares | 0.12 | Common equity | Long | USA |
Merus NV
|
8.75 mm | 318.25 k shares | 0.12 | Common equity | Long | Netherlands |
ABCL AbCellera Biologics Inc | 8.46 mm | 1.48 mm shares | 0.11 | Common equity | Long | Canada |
AKRO Akero Therapeutics Inc | 8.38 mm | 358.87 k shares | 0.11 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 8.37 mm | 386.46 k shares | 0.11 | Common equity | Long | USA |
MORF Morphic Holding Inc | 8.25 mm | 285.54 k shares | 0.11 | Common equity | Long | USA |
CTKB Cytek BioSciences Inc | 7.96 mm | 872.52 k shares | 0.11 | Common equity | Long | USA |
MOR Morphosys AG | 7.38 mm | 745.00 k shares | 0.10 | Common equity | Long | Germany |
ADMA Adma Biologics Inc | 7.35 mm | 1.63 mm shares | 0.10 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 7.25 mm | 478.65 k shares | 0.10 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 7.24 mm | 245.26 k shares | 0.10 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 7.24 mm | 399.76 k shares | 0.10 | Common equity | Long | USA |
GERN Geron Corp. | 7.23 mm | 3.42 mm shares | 0.10 | Common equity | Long | USA |
Stevanato Group SpA
|
7.12 mm | 260.94 k shares | 0.10 | Common equity | Long | Italy |
MNKD Mannkind Corp | 7.11 mm | 1.95 mm shares | 0.10 | Common equity | Long | USA |
KURA Kura Oncology Inc | 7.07 mm | 491.60 k shares | 0.09 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 7.06 mm | 375.78 k shares | 0.09 | Common equity | Long | USA |
QTRX Quanterix Corp | 7.05 mm | 257.79 k shares | 0.09 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 7.01 mm | 636.33 k shares | 0.09 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 6.91 mm | 361.96 k shares | 0.09 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 6.67 mm | 663.08 k shares | 0.09 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 6.58 mm | 331.21 k shares | 0.09 | Common equity | Long | UK |
AMAM Ambrx Biopharma Inc. | 6.51 mm | 457.46 k shares | 0.09 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 6.36 mm | 159.93 k shares | 0.09 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 6.20 mm | 424.81 k shares | 0.08 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 6.19 mm | 611.11 k shares | 0.08 | Common equity | Long | USA |
ETNB 89bio Inc | 6.17 mm | 552.69 k shares | 0.08 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 5.88 mm | 258.98 k shares | 0.08 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 5.86 mm | 363.19 k shares | 0.08 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 5.72 mm | 181.42 k shares | 0.08 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 5.57 mm | 597.75 k shares | 0.07 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 5.51 mm | 374.49 k shares | 0.07 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 5.42 mm | 218.07 k shares | 0.07 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 5.41 mm | 266.91 k shares | 0.07 | Common equity | Long | USA |
RGNX Regenxbio Inc | 5.37 mm | 299.14 k shares | 0.07 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares | 5.37 mm | 819.70 k shares | 0.07 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 5.26 mm | 275.74 k shares | 0.07 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 5.22 mm | 810.28 k shares | 0.07 | Common equity | Long | UK |
ADPT Adaptive Biotechnologies Corp | 5.22 mm | 1.06 mm shares | 0.07 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 5.18 mm | 589.04 k shares | 0.07 | Common equity | Long | USA |
ZYME Zymeworks Inc. | 5.13 mm | 493.63 k shares | 0.07 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals Inc | 5.06 mm | 360.91 k shares | 0.07 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 4.87 mm | 537.70 k shares | 0.07 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 4.80 mm | 533.94 k shares | 0.06 | Common equity | Long | USA |
OPK Opko Health Inc | 4.73 mm | 3.13 mm shares | 0.06 | Common equity | Long | USA |
CDNA Caredx Inc | 4.69 mm | 390.96 k shares | 0.06 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 4.57 mm | 328.16 k shares | 0.06 | Common equity | Long | USA |
Kiniksa Pharmaceuticals Ltd., Class A
|
4.57 mm | 260.72 k shares | 0.06 | Common equity | Long | Bermuda |
APGE Apogee Therapeutics Inc. | 4.52 mm | 161.71 k shares | 0.06 | Common equity | Long | USA |
IRON Disc Medicine Inc | 4.31 mm | 74.58 k shares | 0.06 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 4.25 mm | 391.42 k shares | 0.06 | Common equity | Long | USA |
MGNX Macrogenics Inc | 4.24 mm | 440.75 k shares | 0.06 | Common equity | Long | USA |
FLGT Fulgent Genetics Inc | 4.21 mm | 145.52 k shares | 0.06 | Common equity | Long | USA |
CSTL Castle Biosciences Inc | 4.05 mm | 187.57 k shares | 0.05 | Common equity | Long | USA |
EXAI Exscientia Plc | 4.03 mm | 629.23 k shares | 0.05 | Common equity | Long | UK |
NVAX Novavax, Inc. | 3.98 mm | 829.16 k shares | 0.05 | Common equity | Long | USA |
Theravance Biopharma, Inc.
|
3.91 mm | 347.43 k shares | 0.05 | Common equity | Long | Cayman Islands |
ANAB AnaptysBio Inc | 3.89 mm | 181.64 k shares | 0.05 | Common equity | Long | USA |
ICVX Icosavax Inc | 3.86 mm | 244.75 k shares | 0.05 | Common equity | Long | USA |
GRCL Gracell Biotechnologies Inc | 3.83 mm | 381.04 k shares | 0.05 | Common equity | Long | Cayman Islands |
TNGX Tango Therapeutics Inc | 3.80 mm | 383.47 k shares | 0.05 | Common equity | Long | USA |
ALEC Alector Inc | 3.68 mm | 461.72 k shares | 0.05 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 3.66 mm | 202.70 k shares | 0.05 | Common equity | Long | UK |
FUSN Fusion Pharmaceuticals Inc | 3.62 mm | 376.32 k shares | 0.05 | Common equity | Long | Canada |
NRIX Nurix Therapeutics Inc | 3.47 mm | 335.97 k shares | 0.05 | Common equity | Long | USA |
SLRN Acelyrin Inc | 3.45 mm | 462.38 k shares | 0.05 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 3.34 mm | 165.11 k shares | 0.04 | Common equity | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 3.27 mm | 212.74 k shares | 0.04 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 3.24 mm | 222.89 k shares | 0.04 | Common equity | Long | USA |
MXCT MaxCyte Inc | 3.23 mm | 687.60 k shares | 0.04 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 3.16 mm | 237.31 k shares | 0.04 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 3.13 mm | 546.44 k shares | 0.04 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 3.08 mm | 524.16 k shares | 0.04 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 3.05 mm | 746.53 k shares | 0.04 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
3.01 mm | 200.44 k shares | 0.04 | Common equity | Long | Israel |
FULC Fulcrum Therapeutics Inc | 2.97 mm | 439.82 k shares | 0.04 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 2.94 mm | 268.34 k shares | 0.04 | Common equity | Long | USA |
CureVac NV
|
2.92 mm | 694.55 k shares | 0.04 | Common equity | Long | Netherlands |
REPL Replimune Group Inc | 2.76 mm | 327.42 k shares | 0.04 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
2.75 mm | 544.87 k shares | 0.04 | Common equity | Long | Singapore |
CHRS Coherus Biosciences Inc | 2.71 mm | 814.19 k shares | 0.04 | Common equity | Long | USA |
CMPS Compass Pathways Plc | 2.67 mm | 305.50 k shares | 0.04 | Common equity | Long | UK |
TRML Tourmaline Bio Inc | 2.65 mm | 101.14 k shares | 0.04 | Common equity | Long | USA |
MeiraGTx Holdings plc
|
2.61 mm | 371.13 k shares | 0.03 | Common equity | Long | Cayman Islands |
LIANY LianBio | 2.60 mm | 581.06 k shares | 0.03 | Common equity | Long | China |
ALLO Allogene Therapeutics Inc | 2.57 mm | 800.44 k shares | 0.03 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 2.54 mm | 170.34 k shares | 0.03 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 2.52 mm | 316.72 k shares | 0.03 | Common equity | Long | UK |
SVRA Savara Inc | 2.50 mm | 532.39 k shares | 0.03 | Common equity | Long | USA |
ITOS ITeos Therapeutics Inc | 2.39 mm | 218.04 k shares | 0.03 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corp | 2.38 mm | 952.88 k shares | 0.03 | Common equity | Long | Canada |
JANX Janux Therapeutics Inc | 2.32 mm | 216.16 k shares | 0.03 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 2.25 mm | 266.57 k shares | 0.03 | Common equity | Long | USA |
PRME Prime Medicine Inc | 2.25 mm | 253.73 k shares | 0.03 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 2.22 mm | 850.25 k shares | 0.03 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals Inc | 2.20 mm | 238.73 k shares | 0.03 | Common equity | Long | USA |
uniQure NV
|
2.17 mm | 321.24 k shares | 0.03 | Common equity | Long | Netherlands |
CGEM Cullinan Therapeutics Inc | 2.10 mm | 205.99 k shares | 0.03 | Common equity | Long | USA |
ELVN Enliven Therapeutics Inc | 2.04 mm | 147.21 k shares | 0.03 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals Inc | 1.99 mm | 162.75 k shares | 0.03 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 1.93 mm | 297.87 k shares | 0.03 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals Inc | 1.83 mm | 200.18 k shares | 0.02 | Common equity | Long | USA |